![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/BAFNAPH.png)
Share the post "Bafna Pharmaceuticals Shareholding pattern FY(Q3-Dec 2024-2025)"
Shareholding results offer insight into the distribution of shares among various investors, highlighting the levels of institutional and retail ownership. These results are significant for analyzing investor confidence and market sentiment. Understanding shareholding patterns can aid stakeholders in predicting how changes in ownership might affect a company’s stock performance. Bafna Pharmaceuticals has released its latest shareholding reports, covering the third quarter and the fiscal year ending on (Q3-Dec 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares(in %) | Current Quarter Shares(in %) | Quarter to Quarter Difference |
|---|---|---|---|---|---|
| Promoters | 2.09 Cr | 2.09 Cr | 88.3 | 88.3 | 0 |
| Public | 27.69 Lakh | 27.69 Lakh | 11.7 | 11.7 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters shareholding remained stable, at 88.3% in both September 2024- and December 2024-. This indicates that the promoters’ control over the company did not change during this period. Public shareholding remained consistent, holding steady at 11.7% in both September 2024- and December 2024-. This indicates that the Public control over the company did not change during this period.
Below is a detailed table showcasing the public shareholding percentage.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 11.60 Lakh | 11.50 Lakh | 4.9 | 4.86 | -0.04 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 6.60 Lakh | 6.63 Lakh | 2.79 | 2.8 | + 0.01 % |
| Non Resident Indians (NRIs) | 1.82 Lakh | 1.87 Lakh | 0.77 | 0.79 | + 0.02 % |
| Any Other (specify) | 1.81 Lakh | 1.84 Lakh | 0.77 | 0.78 | + 0.01 % |
| HUF | 91.08 K | 93.60 K | 0.38 | 0.4 | + 0.02 % |
Observations show a significant difference of -0.04 % in Resident Individuals holding nominal share capital up to Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.01 %.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.02 %.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.01 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.02 %.
[my_shortcode1 values=”Bafna Pharmaceuticals”]
